Randomized study of clinical effect of enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer

Clinical Nutrition

Volumn 31, Issue 3, 2012, Pages 330-336

  Miyata, Hiroshi ^a   Yano, Masahiko ^b   Yasuda, Takushi ^c   Hamano, Rie ^a   Yamasaki, Makoto ^a   Hou, Eihou ^c   Motoori, Masaaki ^b   Shiraishi, Osamu ^c   Tanaka, Koji ^b   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Adverse effect; Chemotherapy; Enteral nutrition; Esophageal cancer; Neoadjuvant; Toxicity

Indexed keywords

ALBUMIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; OMEGA 3 FATTY ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TOXICITY; CALORIC INTAKE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CHEMOTHERAPY INDUCED EMESIS; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; ENTERIC FEEDING; ESOPHAGUS CANCER; FEMALE; HUMAN; INCIDENCE; INTESTINE INJURY; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; WEIGHT CHANGE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DIETARY SUPPLEMENTS; DOXORUBICIN; ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; FATTY ACIDS, OMEGA-3; FEMALE; FLUOROURACIL; HUMANS; INCIDENCE; JAPAN; LEUKOPENIA; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; NEUTROPENIA; PATIENT COMPLIANCE;

EID: 84861345919     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.11.002     Document Type: Article

References (38)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Muller J.M., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990, 77:845-857.
3. Refaely Y., Krasna M.J. Multimodality therapy for esophageal cancer. Surg Clin N Am 2002, 82:729-746.
4. Gebski V., Burmeister B., Smithers B.M., Foo K., Zalcberg J., Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007, 8:226-234. Australasian Gastro-Intestinal Trials Group.
5. Walsh T.N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T.P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996, 335:462-467.
6. Tepper J., Krasna M.J., Niedzwiecki D., Hollis D., Reed C.E., Goldberg R., et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Ciln Oncol 2008, 26:1086-1092.
7. Medical Research Council Oesophageal Cancer Working Group Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 2002, 359:1727-1733.
8. Cunningham D., Allum W.H., Stenning S.P., Thompson J.N., Van de Velde C.J., Nicolson M., et al. MAGIC Trial Participants Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355:11-20.
9. Tannock I.F., Goldenberg G.J. Drug resistance and experimental chemotherapy. The basic science of oncology 1998, 418-425. The McGraw-Hill Companies, Inc., New York. 3rd ed. I.F. Tannock, P.H. Richard (Eds.).
10. Baldwin C., Parsons T.J. Dietary advice and nutritional supplements in the management of illness-related malnutrition: systematic review. Clin Nutr 2004, 23:1267-1279.
11. Arends J., Bodoky G., Bozzetti F., Fearon K., Muscaritoli M., Selga G., et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006, 25:245-259. ESPEN (European Society for Parenteral and Enteral Nutrition).
12. August D.A., Huhmann M.B., American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors A.S.P.E.N. Clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. J Parenter Enteral Nutr 2009, 33:472-500.
13. Bozzetti F., Braga M., Gianotti L., Gavazzi C., Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet 2001, 358:1487-1492.
14. Wu G.H., Liu Z.H., Wu Z.H., Wu Z.G. Perioperative artificial nutrition in malnourished gastrointestinal cancer patients. World J Gastroenterol 2006, 12:2441-2444.
15. Braga M., Gianotti L., Gentilini O., Parisi V., Salis C., Di Carlo V. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med 2001, 29:242-248.
16. Malhotra A., Mathur A.K., Gupta S. Early enteral nutrition after surgical treatment of gut perforations: a prospective randomised study. J Postgrad Med 2004, 50:102-106.
17. Elia M., Van Bokhorst-de van der Schueren M.A., Garvey J., Goedhart A., Lundholm K., Nitenberg G., et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006, 28:5-23.
18. Daly J.M., Weintraub F.N., Shou J., Rosato E.F., Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995, 221:327-338.
19. Bozzetti F., Cozzaglio L., Gavazzi C., Bidoli P., Bonfanti G., Montalto F., et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 1998, 84:681-686.
20. Isenring E.A., Capra S., Bauer J.D. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004, 91:447-452.
21. Jho D.H., Cole S.M., Lee E.M., Espat N.J. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther 2004, 3:98-111.
22. Gogos C.A., Ginopoulos P., Salsa B., Apostolidou E., Zoumbos N.C., Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1998, 82:395-402.
23. Barber M.D., Ross J.A., Preston T., Shenkin A., Fearon K.C. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr 1999, 129:1120-1125.
24. Kinsella J.E., Lokesh B., Broughton S., Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990, 6:24-44.
25. Hardman W.E., Moyer M.P., Cameron I.L. Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects. Br J Cancer 1999, 81:440-448.
26. Mitsugi K., Nakamura T., Kashiwabara N., Ariyama H., Tanaka R., Baba E., et al. Protection against methotrexate toxicity by a soybean protein- and omega-3 fatty acid-containing diet: comparative study with a casein-containing diet. Oncol Rep 2004, 12:41-45.
27. Miyata H., Yoshioka A., Yamasaki M., Nushijima Y., Takiguchi S., Fujiwara Y., et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 2009, 115:3324-3334.
28. Japanese Society for Esophageal Diseases Guidelines for the clinical and pathologic studies on carcinoma of the esophagus 2007, Kanehara Syuppan, Tokyo, Japan. 10th ed.
29. Chang F., Deere H., Mahadeva U., George S. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy; Practical guidelines and current issues. Am J Clin Path 2008, 129:252-262.
30. Rey-Ferro M., Castaño R., Orozco O., Serna A., Moreno A. Nutritional and immunologic evaluation of patients with gastric cancer before and after surgery. Nutrition 1997, 13:878-881.
31. van Bokhorst-de van der Schuer M.A.E., van Leeuwen P.A., Kuik D.J., Klop W.M., Sauerwein H.P., Snow G.B., et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999, 86:519-527.
32. Sandström R., Drott C., Hyltander A., Arfvidsson B., Scherstén T., Wickström I., et al. The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg 1993, 217:185-195.
33. Klein S., Koretz R.L. Nutrition support in patients with cancer: what do the data really show?. Nutr Clin Pract 1994, 9:91-100.
34. Yamasaki M., Miyata H., Tanaka K., Shiraishi O., Motoori M., Peng Y.F., et al. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus. Oncology 2011, 80:307-313.
35. Roth A.D., Fazio N., Stupp R., Falk S., Bernhard J., Saletti P., et al. Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 2007, 25:3217-3223.
36. Andreyev H.J., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998, 34:503-509.
37. Hardman W.E., Moyer M.P., Cameron I.L. Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice. Br J Cancer 2002, 86:983-988.
38. Murphy R.A., Mourtzakis M., Chu Q.S., Baracos V.E., Reiman T., Mazurak V.C. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 2011, 117:1775-1782.